Medical and economic impact of autoimmune hepatitis
- 1 August 2002
- journal article
- review article
- Published by Elsevier in Clinics in Liver Disease
- Vol. 6 (3) , 649-667
- https://doi.org/10.1016/s1089-3261(02)00030-2
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trialJournal of Hepatology, 2000
- Ten–Year Survival in Ursodeoxycholic Acid-Treated Patients With Primary Biliary CirrhosisHepatology, 1999
- Drug Therapy in the Management of Type 1 Autoimmune HepatitisDrugs, 1999
- Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosisGastroenterology, 1997
- Azathioprine for Long-Term Maintenance of Remission in Autoimmune HepatitisNew England Journal of Medicine, 1995
- Ursodiol for the Long-Term Treatment of Primary Biliary CirrhosisNew England Journal of Medicine, 1994
- Ursodeoxycholic acid in the treatment of primary biliary cirrhosisGastroenterology, 1994
- A Multicenter, Controlled Trial of Ursodiol for the Treatment of Primary Biliary CirrhosisNew England Journal of Medicine, 1991
- PREVALENCE, INCIDENCE AND DURATIONAmerican Journal of Epidemiology, 1980
- Smoking and Carcinoma of the LungBMJ, 1950